In the present study we used instead patient samples to confirm this involvement of the FREM2 gene and its protein in glioblastoma pathology as the malignancy progresses, as shown by the higher FREM2 expression levels in glioblastoma tissues compared to lower grade gliomas and reference samples. The gene discussed is FREM2; the disease is glioma.